Pain perception description after advanced surface ablation

Eva M Sobas,1,2 Sebastián Videla,3,4 Amanda Vázquez,1 Itziar Fernández,1,5 Miguel J Maldonado,1 José-Carlos Pastor1,6,7 1Instituto Universitario de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain; 2Facultad de Enfe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sobas EM, Videla S, Vázquez A, Fernández I, Maldonado MJ, Pastor JC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/a0f106bbb0fc41cda2cb2d850a607013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a0f106bbb0fc41cda2cb2d850a607013
record_format dspace
spelling oai:doaj.org-article:a0f106bbb0fc41cda2cb2d850a6070132021-12-02T11:29:25ZPain perception description after advanced surface ablation1177-5483https://doaj.org/article/a0f106bbb0fc41cda2cb2d850a6070132017-04-01T00:00:00Zhttps://www.dovepress.com/pain-perception-description-after-advanced-surface-ablation-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Eva M Sobas,1,2 Sebastián Videla,3,4 Amanda Vázquez,1 Itziar Fernández,1,5 Miguel J Maldonado,1 José-Carlos Pastor1,6,7 1Instituto Universitario de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain; 2Facultad de Enfermería, Universidad de Valladolid, Valladolid Spain; 3Laboratorios Dr. Esteve S.A., Barcelona, Spain; 4Department of Experimental and Health Sciences, Facultad de Ciencias de la Salud y de la Vida, Universidad Pompeu Fabra, Barcelona, Spain; 5Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain; 6Department of Ophthalmology, Hospital Clínico Universitario, Valladolid, Spain; 7Department of Surgery, Ophthalmology, Otorhinolaryngology and Physiotherapy, Facultad de Medicina, Universidad de Valladolid, Valladolid, Spain Purpose: The objective of this study was to characterize the evolution of ocular pain after advanced surface ablation (ASA) to improve strategies in postoperative pain management.Methods: This was a multicenter, prospective, descriptive, cohort study. The inclusion criteria were healthy individuals ≥18 years old receiving bilateral alcohol-assisted surface ablation with epithelial removal. Pain intensity was evaluated with the visual analog scale (VAS) and the numeric pain rating scale before and after surgery. Comorbidities (photophobia, burning, tearing, and foreign body sensation) and Hospital Anxiety and Depression (HAD) questionnaire were evaluated before and at 6 hours after surgery. Postoperative treatments included cold patch, topical cold antibiotics, topical steroids, and benzodiazepines.Results: Thirty-two consecutive patients having similar profiles of postoperative pain evolution were included. At 0.5 hour after ASA, the pain score by VAS was 37±20 mm, and the maximum pain, 61±31 mm, occurred at 24 hours. Afterward, it decreased progressively until 72 hours after surgery (19±20 mm). Most patients (81%) scored >60 mm, and 44% required rescue medication. Among the comorbidities, all patients had photophobia and 84% had burning sensation. At 6 hours, the HAD score was 5.4±3.9, within the range of values considered as normal.Conclusion: Postoperative acute ocular pain after ASA showed a characteristic evolution over time. Recognition of the pattern could be important for improving the acceptance of ASA and for improving strategies in pain management in the postoperative period. Keywords: ocular pain, advanced surface ablation, model acute surgical painSobas EMVidela SVázquez AFernández IMaldonado MJPastor JCDove Medical Pressarticleocular painAdvanced Surface Ablationmodel acute surgical pain.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 647-655 (2017)
institution DOAJ
collection DOAJ
language EN
topic ocular pain
Advanced Surface Ablation
model acute surgical pain.
Ophthalmology
RE1-994
spellingShingle ocular pain
Advanced Surface Ablation
model acute surgical pain.
Ophthalmology
RE1-994
Sobas EM
Videla S
Vázquez A
Fernández I
Maldonado MJ
Pastor JC
Pain perception description after advanced surface ablation
description Eva M Sobas,1,2 Sebastián Videla,3,4 Amanda Vázquez,1 Itziar Fernández,1,5 Miguel J Maldonado,1 José-Carlos Pastor1,6,7 1Instituto Universitario de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain; 2Facultad de Enfermería, Universidad de Valladolid, Valladolid Spain; 3Laboratorios Dr. Esteve S.A., Barcelona, Spain; 4Department of Experimental and Health Sciences, Facultad de Ciencias de la Salud y de la Vida, Universidad Pompeu Fabra, Barcelona, Spain; 5Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain; 6Department of Ophthalmology, Hospital Clínico Universitario, Valladolid, Spain; 7Department of Surgery, Ophthalmology, Otorhinolaryngology and Physiotherapy, Facultad de Medicina, Universidad de Valladolid, Valladolid, Spain Purpose: The objective of this study was to characterize the evolution of ocular pain after advanced surface ablation (ASA) to improve strategies in postoperative pain management.Methods: This was a multicenter, prospective, descriptive, cohort study. The inclusion criteria were healthy individuals ≥18 years old receiving bilateral alcohol-assisted surface ablation with epithelial removal. Pain intensity was evaluated with the visual analog scale (VAS) and the numeric pain rating scale before and after surgery. Comorbidities (photophobia, burning, tearing, and foreign body sensation) and Hospital Anxiety and Depression (HAD) questionnaire were evaluated before and at 6 hours after surgery. Postoperative treatments included cold patch, topical cold antibiotics, topical steroids, and benzodiazepines.Results: Thirty-two consecutive patients having similar profiles of postoperative pain evolution were included. At 0.5 hour after ASA, the pain score by VAS was 37±20 mm, and the maximum pain, 61±31 mm, occurred at 24 hours. Afterward, it decreased progressively until 72 hours after surgery (19±20 mm). Most patients (81%) scored >60 mm, and 44% required rescue medication. Among the comorbidities, all patients had photophobia and 84% had burning sensation. At 6 hours, the HAD score was 5.4±3.9, within the range of values considered as normal.Conclusion: Postoperative acute ocular pain after ASA showed a characteristic evolution over time. Recognition of the pattern could be important for improving the acceptance of ASA and for improving strategies in pain management in the postoperative period. Keywords: ocular pain, advanced surface ablation, model acute surgical pain
format article
author Sobas EM
Videla S
Vázquez A
Fernández I
Maldonado MJ
Pastor JC
author_facet Sobas EM
Videla S
Vázquez A
Fernández I
Maldonado MJ
Pastor JC
author_sort Sobas EM
title Pain perception description after advanced surface ablation
title_short Pain perception description after advanced surface ablation
title_full Pain perception description after advanced surface ablation
title_fullStr Pain perception description after advanced surface ablation
title_full_unstemmed Pain perception description after advanced surface ablation
title_sort pain perception description after advanced surface ablation
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/a0f106bbb0fc41cda2cb2d850a607013
work_keys_str_mv AT sobasem painperceptiondescriptionafteradvancedsurfaceablation
AT videlas painperceptiondescriptionafteradvancedsurfaceablation
AT vazqueza painperceptiondescriptionafteradvancedsurfaceablation
AT fernandezi painperceptiondescriptionafteradvancedsurfaceablation
AT maldonadomj painperceptiondescriptionafteradvancedsurfaceablation
AT pastorjc painperceptiondescriptionafteradvancedsurfaceablation
_version_ 1718395896993939456